{"title":"紫檀种子对DMBA-诱导的大鼠乳腺癌症的抗肿瘤作用。","authors":"Vivek Akhouri, Arun Kumar, Manorma Kumari","doi":"10.1177/1178223420951193","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer has been one of the most common form of malignancy globally among women, for more than a decade. Despite various preventive and treatment measures, it remains associated with high incidence and mortality rate. <i>Pterocarpus santalinus</i> Linn. f. has been extensively used in Indian medicine system <i>Ayurveda</i>, due to its various medicinal properties. However, despite various research works on the anticancer activity of <i>P santalinus</i>, no studies have been reported on animal model. Therefore, this study was aimed to decipher the antitumour activity of ethanolic seeds extract of <i>P santalinus</i> on DMBA (7,12-dimethylbenz(a)-anthracene)-induced breast cancer in rats. Fifty-five-days-old weighed (150 ± 10 g) female Charles Foster rats (12 females) were used for the study. The rats were divided into 3 groups of 4 rats each. 7,12-Dimethylbenz(a)-anthracene (single dose of 20 mg/mL dissolved in olive oil) was induced orally, to develop breast tumour. After the development of breast tumours (about 0.5 cm), the rats were treated with <i>P santalinus</i> ethanolic seeds extract (300 mg/kg body weight/day) orally for 5 weeks and then volume of tumour was measured. Oral administration of <i>P santalinus</i> extract resulted in about 49.5% tumour growth inhibition in the final week of treatment in DMBA + <i>P santalinus</i> group as compared with the DMBA group. <i>Pterocarpus santalinus</i> administration also significantly reduced (<i>P</i> < .0001) the serum malondialdehyde level from 58.81 ± 4.09 nmol/mL in DMBA group to 10.87 ± 1.20 nmol/mL in the DMBA + <i>P santalinus</i> group. Serum tumour necrosis factor-α level reduced significantly (<i>P</i> < .0001) from 80.43 ± 2.45 pg/mL in DMBA group to 28.30 ± 3.24 pg/mL in the DMBA + <i>P santalinus</i> group. The blood serum glucose level also reduced significantly (<i>P</i> < .0001) from 205.9 ± 22.22 mg/dL in DMBA group to 86.44 ± 8.36 in DMBA + <i>P santalinus</i> group. There was significant (<i>P</i> <i><</i> .0001) improvement in the both the liver and kidney serum biomarkers level after <i>P santalinus</i> administration. The histological study of mammary tissues of rats shows that, in the DMBA group immature fibrocytes are completely replacing the normal adipocytes suggestive of fibroma molle, whereas in the DMBA + <i>P santalinus</i> group mature fibrocytes with multilayer glandular cells were seen denoting fibroadenoma. Thus, the <i>P santalinus</i> ethanolic seed extract possesses antitumorigenic, antioxidant and hypoglycaemic properties as well as hepato-renal protective effect. Hence, it may be concluded that <i>P santalinus</i> has therapeutic role against DMBA-induced breast cancer in rats and has a greater potential to develop as a chemotherapeutic agent in breast cancer treatment.</p>","PeriodicalId":9163,"journal":{"name":"Breast Cancer : Basic and Clinical Research","volume":"14 ","pages":"1178223420951193"},"PeriodicalIF":1.8000,"publicationDate":"2020-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/7d/10.1177_1178223420951193.PMC7444153.pdf","citationCount":"0","resultStr":"{\"title\":\"Antitumour Property of <i>Pterocarpus santalinus</i> Seeds Against DMBA-Induced Breast Cancer in Rats.\",\"authors\":\"Vivek Akhouri, Arun Kumar, Manorma Kumari\",\"doi\":\"10.1177/1178223420951193\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Breast cancer has been one of the most common form of malignancy globally among women, for more than a decade. Despite various preventive and treatment measures, it remains associated with high incidence and mortality rate. <i>Pterocarpus santalinus</i> Linn. f. has been extensively used in Indian medicine system <i>Ayurveda</i>, due to its various medicinal properties. However, despite various research works on the anticancer activity of <i>P santalinus</i>, no studies have been reported on animal model. Therefore, this study was aimed to decipher the antitumour activity of ethanolic seeds extract of <i>P santalinus</i> on DMBA (7,12-dimethylbenz(a)-anthracene)-induced breast cancer in rats. Fifty-five-days-old weighed (150 ± 10 g) female Charles Foster rats (12 females) were used for the study. The rats were divided into 3 groups of 4 rats each. 7,12-Dimethylbenz(a)-anthracene (single dose of 20 mg/mL dissolved in olive oil) was induced orally, to develop breast tumour. After the development of breast tumours (about 0.5 cm), the rats were treated with <i>P santalinus</i> ethanolic seeds extract (300 mg/kg body weight/day) orally for 5 weeks and then volume of tumour was measured. Oral administration of <i>P santalinus</i> extract resulted in about 49.5% tumour growth inhibition in the final week of treatment in DMBA + <i>P santalinus</i> group as compared with the DMBA group. <i>Pterocarpus santalinus</i> administration also significantly reduced (<i>P</i> < .0001) the serum malondialdehyde level from 58.81 ± 4.09 nmol/mL in DMBA group to 10.87 ± 1.20 nmol/mL in the DMBA + <i>P santalinus</i> group. Serum tumour necrosis factor-α level reduced significantly (<i>P</i> < .0001) from 80.43 ± 2.45 pg/mL in DMBA group to 28.30 ± 3.24 pg/mL in the DMBA + <i>P santalinus</i> group. The blood serum glucose level also reduced significantly (<i>P</i> < .0001) from 205.9 ± 22.22 mg/dL in DMBA group to 86.44 ± 8.36 in DMBA + <i>P santalinus</i> group. There was significant (<i>P</i> <i><</i> .0001) improvement in the both the liver and kidney serum biomarkers level after <i>P santalinus</i> administration. The histological study of mammary tissues of rats shows that, in the DMBA group immature fibrocytes are completely replacing the normal adipocytes suggestive of fibroma molle, whereas in the DMBA + <i>P santalinus</i> group mature fibrocytes with multilayer glandular cells were seen denoting fibroadenoma. Thus, the <i>P santalinus</i> ethanolic seed extract possesses antitumorigenic, antioxidant and hypoglycaemic properties as well as hepato-renal protective effect. Hence, it may be concluded that <i>P santalinus</i> has therapeutic role against DMBA-induced breast cancer in rats and has a greater potential to develop as a chemotherapeutic agent in breast cancer treatment.</p>\",\"PeriodicalId\":9163,\"journal\":{\"name\":\"Breast Cancer : Basic and Clinical Research\",\"volume\":\"14 \",\"pages\":\"1178223420951193\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2020-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/7d/10.1177_1178223420951193.PMC7444153.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer : Basic and Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1178223420951193\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer : Basic and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1178223420951193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
十多年来,癌症一直是全球女性最常见的恶性肿瘤之一。尽管采取了各种预防和治疗措施,但它仍然与高发病率和死亡率有关。紫檀。f.由于其各种药用特性,在印度医学体系阿育吠陀中被广泛使用。然而,尽管对桑塔利努斯的抗癌活性进行了各种研究,但还没有关于动物模型的研究报告。因此,本研究旨在阐明人参乙醇籽提取物对DMBA(7,12-二甲基苯(a)-蒽)诱导的大鼠乳腺癌症的抗肿瘤活性。五十五天大,体重(150 ± 10 g) 雌性Charles Foster大鼠(12只雌性)用于该研究。将大鼠分为3组,每组4只。7,12-二甲基苯(a)-蒽(单剂量20 mg/mL溶于橄榄油中)经口诱导产生乳腺肿瘤。乳腺肿瘤发生后(约0.5 cm),用人参乙醇种子提取物(300 mg/kg体重/天)口服5 周,然后测量肿瘤体积。口服人参提取物在DMBA治疗的最后一周导致约49.5%的肿瘤生长抑制 + P santalinus组与DMBA组比较。紫檀给药也显著降低(P P santalinus组。血清肿瘤坏死因子-α水平显著降低(P P santalinus组。血糖水平也明显下降(P P santalinus组。有显著性差异(P .0001)肝和肾血清生物标志物水平的改善。对大鼠乳腺组织的组织学研究表明,在DMBA组中,未成熟的纤维细胞完全取代了正常的脂肪细胞,这提示了molle纤维瘤,而在DMBA中 + 桑塔利努斯组的成熟纤维细胞和多层腺细胞表示纤维腺瘤。因此,人参乙醇籽提取物具有抗肿瘤、抗氧化和降血糖的特性以及肝肾保护作用。因此,可以得出结论,P santalinus对DMBA诱导的大鼠乳腺癌症具有治疗作用,并具有更大的发展潜力,作为一种治疗癌症的化疗剂。
Antitumour Property of Pterocarpus santalinus Seeds Against DMBA-Induced Breast Cancer in Rats.
Breast cancer has been one of the most common form of malignancy globally among women, for more than a decade. Despite various preventive and treatment measures, it remains associated with high incidence and mortality rate. Pterocarpus santalinus Linn. f. has been extensively used in Indian medicine system Ayurveda, due to its various medicinal properties. However, despite various research works on the anticancer activity of P santalinus, no studies have been reported on animal model. Therefore, this study was aimed to decipher the antitumour activity of ethanolic seeds extract of P santalinus on DMBA (7,12-dimethylbenz(a)-anthracene)-induced breast cancer in rats. Fifty-five-days-old weighed (150 ± 10 g) female Charles Foster rats (12 females) were used for the study. The rats were divided into 3 groups of 4 rats each. 7,12-Dimethylbenz(a)-anthracene (single dose of 20 mg/mL dissolved in olive oil) was induced orally, to develop breast tumour. After the development of breast tumours (about 0.5 cm), the rats were treated with P santalinus ethanolic seeds extract (300 mg/kg body weight/day) orally for 5 weeks and then volume of tumour was measured. Oral administration of P santalinus extract resulted in about 49.5% tumour growth inhibition in the final week of treatment in DMBA + P santalinus group as compared with the DMBA group. Pterocarpus santalinus administration also significantly reduced (P < .0001) the serum malondialdehyde level from 58.81 ± 4.09 nmol/mL in DMBA group to 10.87 ± 1.20 nmol/mL in the DMBA + P santalinus group. Serum tumour necrosis factor-α level reduced significantly (P < .0001) from 80.43 ± 2.45 pg/mL in DMBA group to 28.30 ± 3.24 pg/mL in the DMBA + P santalinus group. The blood serum glucose level also reduced significantly (P < .0001) from 205.9 ± 22.22 mg/dL in DMBA group to 86.44 ± 8.36 in DMBA + P santalinus group. There was significant (P< .0001) improvement in the both the liver and kidney serum biomarkers level after P santalinus administration. The histological study of mammary tissues of rats shows that, in the DMBA group immature fibrocytes are completely replacing the normal adipocytes suggestive of fibroma molle, whereas in the DMBA + P santalinus group mature fibrocytes with multilayer glandular cells were seen denoting fibroadenoma. Thus, the P santalinus ethanolic seed extract possesses antitumorigenic, antioxidant and hypoglycaemic properties as well as hepato-renal protective effect. Hence, it may be concluded that P santalinus has therapeutic role against DMBA-induced breast cancer in rats and has a greater potential to develop as a chemotherapeutic agent in breast cancer treatment.
期刊介绍:
Breast Cancer: Basic and Clinical Research is an international, open access, peer-reviewed, journal which considers manuscripts on all areas of breast cancer research and treatment. We welcome original research, short notes, case studies and review articles related to breast cancer-related research. Specific areas of interest include, but are not limited to, breast cancer sub types, pathobiology, metastasis, genetics and epigenetics, mammary gland biology, breast cancer models, prevention, detection, therapy and clinical interventions, and epidemiology and population genetics.